Pharmanovia has signed a licensing agreement with Lindis Biotech to commercialise catumaxomab, a new trifunctional ...

The agreement gives Pharmanovia the exclusive rights to bring to market, catumaxomab, a first-in-class, trifunctional bi-specific monoclonal antibody, indicated for the intraperitoneal treatment of ...

Joseph Ambani, a Medical Doctor at GlowBar, has shared the top symptom for liver cancer which can be spotted during the early ...

The damage caused by cirrhosis can’t be undone, however, if the condition is diagnosed early and the underlying cause is ...